½ÃÀ庸°í¼­
»óǰÄÚµå
1589516

µðÁöÅÐ Ä¡·á±â±â ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Digital Therapeutic Devices Market by Product (Insulin Pumps, Pain Management Devices, Rehabilitation Devices), Application (Preventive, Treatment) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

µðÁöÅÐ Ä¡·á±â±â(Digital Therapeutic Devices) ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 62¾ï 6,000¸¸ ´Þ·¯¿´À¸¸ç, 2024³â¿¡´Â 74¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤ µÇ¸ç, CAGR 18.39%·Î ÃßÀÌÇÏ¸ç ¼ºÀåÇØ 2030³â¿¡´Â 204¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µðÁöÅÐ Ä¡·á±â±â(DTD)´Â ´Ù¾çÇÑ ÀÇ·á ÁúȯÀ» ¿¹¹æ, °ü¸® ¶Ç´Â Ä¡·áÇϱâ À§ÇÑ ¼ÒÇÁÆ®¿þ¾î ÇÁ·Î±×·¥À» ÅëÇØ ȯÀÚ¿¡°Ô Áõ°Å ±â¹Ý Ä¡·á °³ÀÔÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ÀÇ·á ±â¼ú ºÐ¾ß¿¡¼­ ¿ªµ¿ÀûÀ̰í È®ÀåÀûÀÎ ºÐ¾ßÀÔ´Ï´Ù. DTDÀÇ Çʿ伺Àº °³ÀÎÈ­µÈ Ä¡·á ¿É¼ÇÀ» Á¦°øÇϰí, ȯÀÚ Âü¿©¸¦ °³¼±Çϸç, °Ç°­ °ü¸®¿¡ ´ëÇÑ µ¥ÀÌÅÍ ±â¹Ý ÀλçÀÌÆ®¸¦ Á¦°øÇÏ¿© °Ç°­ °á°ú¸¦ °³¼±ÇÏ´Â µ¿½Ã¿¡ ÀÇ·á ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ °­Á¶µË´Ï´Ù. À̵éÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ, ȯÀÚ, º¸Çè»ç, °í¿ëÁÖ¸¦ Æ÷ÇÔÇÑ ÃÖÁ¾ »ç¿ëÀÚ¸¦ ÅëÇØ ¸¸¼º Áúȯ °ü¸®, Á¤½Å °Ç°­ Áö¿ø, ¾à¹° ³²¿ë Ä¡·á, ÀçȰ µî ´Ù¾çÇÑ ¿µ¿ª¿¡¼­ ¾ÖÇø®ÄÉÀ̼ÇÀ» ã½À´Ï´Ù. ½º¸¶Æ®Æù°ú ÀÎÅͳÝÀÇ Ã¤Åà Áõ°¡, ¸¸¼º Áúȯ À¯º´·ü Áõ°¡, ÀÇ·á ºñ¿ë »ó½ÂÀº ÁÖ¿ä ¼ºÀå µ¿·ÂÀÔ´Ï´Ù. ¶ÇÇÑ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¿¹¹æÀû ÀÇ·á ¼­ºñ½º·ÎÀÇ ¼ÒºñÀÚ À̵¿Àº Çõ½Å°ú ½ÃÀå È®ÀåÀ» À§ÇÑ »ó´çÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ½ÃÀåÀº ±ÔÁ¦ ¹®Á¦, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¿ì·Á, È¿´É ÁÖÀåÀ» µÞ¹ÞħÇÒ º¸´Ù °­·ÂÇÑ ÀÓ»ó Áõ°ÅÀÇ Çʿ伺 µîÀÇ Á¦ÇÑ¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ µðÁöÅÐ ÀÇ·á ¼Ö·ç¼Ç°ú °ü·ÃµÈ µðÁöÅÐ ¸®ÅÍ·¯½Ã À庮°ú ½Å·Ú ¹®Á¦·Î ÀÎÇØ ȯÀÚ Ã¤ÅÃÀÌ ¹æÇعÞÀ» ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀÇ ÁÖ¿ä ºÐ¾ß·Î´Â AI ±â¹Ý °³ÀÎ ¸ÂÃãÇü Ä¡·á ¼Ö·ç¼Ç °­È­, ¾ÈÀüÇÑ µ¥ÀÌÅÍ °ü¸®¸¦ À§ÇÑ ºí·ÏüÀÎ ÅëÇÕ, ȯÀÚ ¼øÀÀµµ Çâ»óÀ» À§ÇÑ »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º °³¹ß µîÀÌ ÀÖ½À´Ï´Ù. ±â¾÷Àº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿Í ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇÏ¿© ½ÃÀå ħÅõ¸¦ º¸ÀåÇÏ°í ½ÇÁ¦ Áõ°Å¸¦ Ȱ¿ëÇÏ¿© ±ÔÁ¦ ½ÂÀÎÀ» ¹Þ´Â µ¥ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. µð¹ÙÀ̽º È¿´É ¹× ȯÀÚ Âü¿© Àü·«¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ßÀº ÀÌ·¯ÇÑ °æÀï ½ÃÀå¿¡¼­ ¼ºÀåÀ» À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÒ °ÍÀÔ´Ï´Ù. ½ÃÀåÀÇ Æ¯¼º»ó Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀÌ ºü¸£°Ô ÁøÇàµÇ°í Àֱ⠶§¹®¿¡ ±ÔÁ¦ ȯ°æ°ú ¼ÒºñÀÚ ¼±È£µµ¸¦ ¿°µÎ¿¡ µÎ°í »õ·Î¿î Æ®·»µå¸¦ Ȱ¿ëÇϱâ À§Çؼ­´Â ¹Îø¼º°ú ¼±°ßÁö¸íÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 62¾ï 6,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 74¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 204¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 18.39%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â µðÁöÅÐ Ä¡·á±â±â ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

µðÁöÅÐ Ä¡·á±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼ºÁúȯ Áõ°¡¿Í ¿¹¹æÀÇ·á¿¡ ´ëÇÑ ÁÖ¸ñ Áõ°¡
    • ÀÇ·á±â±âÀÇ µðÁöÅÐÈ­ÀÇ ÁøÀü
    • ¿ø°ÝÀÇ·á¿Í ¿ø°ÝÄ¡·á¸¦ ÃßÁøÇÏ´Â Á¤ºÎ ´ëó
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ȯÀÚ µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã¿¡ °üÇÑ ¿ì·Á
  • ½ÃÀå ±âȸ
    • µðÁöÅÐ Ä¡·á±â±â¿¡¼­ ½Å±â¼úÀÇ ÅëÇÕ
    • µðÁöÅÐ °Ç°­ »ç¾÷ È®´ë¸¦ À§ÇÑ ÀÚ±Ý Á¶´Þ ¹× ÅõÀÚ Áõ°¡
  • ½ÃÀå °úÁ¦
    • µðÁöÅÐ Ä¡·áÁ¦ÀÇ µµÀÔ¿¡ ´ëÇÑ È¯ÀÚÀÇ ¼Ò±Ø¼º
    • ½ÅÈï±¹¿¡¼­ µðÁöÅÐ Ä¡·á ÇÁ·Î±×·¥ÀÇ °æÇè ¹× ¾×¼¼½º ºÎÁ·

Porter's Five Forces : µðÁöÅÐ Ä¡·á±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : µðÁöÅÐ Ä¡·á±â±â ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº µðÁöÅÐ Ä¡·á±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ý·üÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : µðÁöÅÐ Ä¡·á±â±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

µðÁöÅÐ Ä¡·á±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀÎ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý ¹× ¼ºÀå·üÀ» Æ÷ÇÔÇÑ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© °ø±Þ¾÷ü°¡ Á¡Á¡ ´õ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : µðÁöÅÐ Ä¡·á±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â µðÁöÅÐ Ä¡·á±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¿¡ ±â¹ÝÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Á¦¾È : µðÁöÅÐ Ä¡·á±â±â ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æ ã±â

µðÁöÅÐ Ä¡·á±â±â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº Àü ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º Áúȯ Áõ°¡¿Í ¿¹¹æ Çコ Äɾ ´ëÇÑ ÁÖ¸ñ È®´ë
      • ÀÇ·á±â±âÀÇ µðÁöÅÐÈ­ÀÇ ÁøÀü
      • ¿ø°ÝÀÇ·á¿Í ¿ø°ÝÁø·á¸¦ ÃËÁøÇÏ´Â Á¤ºÎ ´ëó
    • ¾ïÁ¦¿äÀÎ
      • ȯÀÚ µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã¿¡ °üÇÑ ¿ì·Á
    • ±âȸ
      • µðÁöÅÐ Ä¡·á±â±â¿¡¼­ »õ·Î¿î ±â¼úÀÇ ÅëÇÕ
      • µðÁöÅÐ Çコ »ç¾÷ È®´ë¸¦ À§ÇÑ ÀÚ±Ý Á¶´Þ°ú ÅõÀÚ Áõ°¡
    • °úÁ¦
      • µðÁöÅÐÄ¡·áÀÇ µµÀÔ¿¡ ´ëÇÑ È¯ÀÚÀÇ ¼Ò±ØÀû ŵµ
      • ½ÅÈï±¹ÀÇ µðÁöÅÐ Ä¡·á ÇÁ·Î±×·¥ÀÇ °æÇè°ú Á¢±Ù ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ý·üÀû
    • ȯ°æÀû

Á¦6Àå µðÁöÅÐ Ä¡·á±â±â ½ÃÀå : Á¦Ç°º°

  • Àν¶¸° ÆßÇÁ
  • ÅëÁõ °ü¸® ±â±â
  • ÀçȰ Àåºñ
  • È£Èí Ä¡·á±â±â

Á¦7Àå µðÁöÅÐ Ä¡·á±â±â ½ÃÀå : ¿ëµµº°

  • ¿¹¹æ
    • ºñ¸¸
    • ´ç´¢º´ ÀüÁõ
    • ±Ý¿¬
  • Ä¡·á
    • ½ÉÇ÷°ü Áúȯ
    • ÁßÃß ½Å°æ°è Áúȯ
    • ´ç´¢º´
    • ±Ù°ñ°Ý°è Áúȯ
    • È£Èí±â Áúȯ

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ µðÁöÅÐ Ä¡·á±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ µðÁöÅÐ Ä¡·á±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µðÁöÅÐ Ä¡·á±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Axonics, Inc.
  • BioTelemetry, Inc. by Koninklijke Philips NV
  • Blue Mesa Health
  • Canary Health Technologies Inc.
  • Eko Devices, Inc.
  • EMulate Therapeutics, Inc.
  • eNeura Inc.
  • Epillo Health Systems OU
  • Firstbeat Technologies Oy
  • Fitbit International Limited
  • Glooko, Inc.
  • Medtronic PLC
  • Nanobiosym, Inc.
  • Omada Health, Inc.
  • Pear Therapeutics, Inc.
LYJ

The Digital Therapeutic Devices Market was valued at USD 6.26 billion in 2023, expected to reach USD 7.41 billion in 2024, and is projected to grow at a CAGR of 18.39%, to USD 20.42 billion by 2030.

Digital Therapeutic Devices (DTDs) represent a dynamic and expanding sector within healthcare technology, aimed at delivering evidence-based therapeutic interventions to patients via software programs to prevent, manage, or treat various medical conditions. The necessity for DTDs is underscored by their ability to offer personalized treatment options, improve patient engagement, and provide data-driven insights into health management, thereby enhancing health outcomes while reducing healthcare costs. They find applications across various domains such as chronic disease management, mental health support, substance abuse treatment, and rehabilitation, with end-users including healthcare providers, patients, insurers, and employers. The growing adoption of smartphones and the internet, increasing prevalence of chronic diseases, and rising healthcare costs are major growth drivers. Furthermore, the escalating demand for remote patient monitoring solutions and the consumer shift towards preventive healthcare present significant opportunities for innovation and market expansion. However, this market faces limitations such as regulatory challenges, data privacy concerns, and a need for more robust clinical evidence to support efficacy claims. Additionally, patient adoption can be hindered by digital literacy barriers and trust issues related to digital health solutions. Key areas for innovation include enhancing AI-driven personalized care solutions, integrating blockchain for secure data management, and developing user-friendly interfaces to improve patient adherence. Companies could focus on establishing partnerships with healthcare providers to ensure market penetration and leverage real-world evidence to gain regulatory approvals. Ongoing research and development into device efficacy and patient engagement strategies will be crucial for sustaining growth in this competitive market. The market's nature is fast-paced with continuous technological advancements, necessitating agility and foresight to capitalize on emerging trends, while being mindful of regulatory landscapes and consumer preferences.

KEY MARKET STATISTICS
Base Year [2023] USD 6.26 billion
Estimated Year [2024] USD 7.41 billion
Forecast Year [2030] USD 20.42 billion
CAGR (%) 18.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Therapeutic Devices Market

The Digital Therapeutic Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing rate of chronic diseases and rising focus on preventive healthcare
    • Rising digitalization of medical devices
    • Government initiatives promoting telehealth and telemedicine
  • Market Restraints
    • Patient data privacy concerns
  • Market Opportunities
    • New technology integrations in digital therapeutic devices
    • Rising funding and investments for expanding digital health businesses
  • Market Challenges
    • Reluctance among patients to adopt digital therapeutics
    • Lack of experience and access to digital therapeutics programs in emerging countries

Porter's Five Forces: A Strategic Tool for Navigating the Digital Therapeutic Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Therapeutic Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Therapeutic Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Therapeutic Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Therapeutic Devices Market

A detailed market share analysis in the Digital Therapeutic Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Therapeutic Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Therapeutic Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Therapeutic Devices Market

A strategic analysis of the Digital Therapeutic Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Therapeutic Devices Market, highlighting leading vendors and their innovative profiles. These include Axonics, Inc., BioTelemetry, Inc. by Koninklijke Philips N.V., Blue Mesa Health, Canary Health Technologies Inc., Eko Devices, Inc., EMulate Therapeutics, Inc., eNeura Inc., Epillo Health Systems OU, Firstbeat Technologies Oy, Fitbit International Limited, Glooko, Inc., Medtronic PLC, Nanobiosym, Inc., Omada Health, Inc., and Pear Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Therapeutic Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Insulin Pumps, Pain Management Devices, Rehabilitation Devices, and Respiratory Therapy Devices.
  • Based on Application, market is studied across Preventive and Treatment. The Preventive is further studied across Obesity, Pre-Diabetes, and Smoking Cessation. The Treatment is further studied across Cardiovascular Diseases, Central Nervous System Disease, Diabetes, Musculoskeletal Diseases, and Respiratory Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing rate of chronic diseases and rising focus on preventive healthcare
      • 5.1.1.2. Rising digitalization of medical devices
      • 5.1.1.3. Government initiatives promoting telehealth and telemedicine
    • 5.1.2. Restraints
      • 5.1.2.1. Patient data privacy concerns
    • 5.1.3. Opportunities
      • 5.1.3.1. New technology integrations in digital therapeutic devices
      • 5.1.3.2. Rising funding and investments for expanding digital health businesses
    • 5.1.4. Challenges
      • 5.1.4.1. Reluctance among patients to adopt digital therapeutics
      • 5.1.4.2. Lack of experience and access to digital therapeutics programs in emerging countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Therapeutic Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Insulin Pumps
  • 6.3. Pain Management Devices
  • 6.4. Rehabilitation Devices
  • 6.5. Respiratory Therapy Devices

7. Digital Therapeutic Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Preventive
    • 7.2.1. Obesity
    • 7.2.2. Pre-Diabetes
    • 7.2.3. Smoking Cessation
  • 7.3. Treatment
    • 7.3.1. Cardiovascular Diseases
    • 7.3.2. Central Nervous System Disease
    • 7.3.3. Diabetes
    • 7.3.4. Musculoskeletal Diseases
    • 7.3.5. Respiratory Diseases

8. Americas Digital Therapeutic Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Therapeutic Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Therapeutic Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Axonics, Inc.
  • 2. BioTelemetry, Inc. by Koninklijke Philips N.V.
  • 3. Blue Mesa Health
  • 4. Canary Health Technologies Inc.
  • 5. Eko Devices, Inc.
  • 6. EMulate Therapeutics, Inc.
  • 7. eNeura Inc.
  • 8. Epillo Health Systems OU
  • 9. Firstbeat Technologies Oy
  • 10. Fitbit International Limited
  • 11. Glooko, Inc.
  • 12. Medtronic PLC
  • 13. Nanobiosym, Inc.
  • 14. Omada Health, Inc.
  • 15. Pear Therapeutics, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦